Accuray reported $104.68M in Cash and Equivalent for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Accuray ARAY:US $ 104.68M 11.69M
Atricure ATRC:US $ 119.75M 52.13M
Cardiovascular Systems CSII:US $ 66.86M 4.21M
Cryolife CRY:US $ 64.59M 14.11M
Edwards Lifesciences EW:US $ 1506.9M 194.1M
Genmark Diagnostics GNMK:US $ 40.57M 17.24M
Hologic HOLX:US $ 1170.3M 342.7M
Inogen INGN:US $ 241.58M 2.73M
Mesa Laboratories MLAB:US $ 278.29M 2.58M
Natus Medical BABY:US $ 68.78M 6.28M
Orthofix International OFIX:US $ 82.71M 2.74M
Oxford Immunotec Global OXFD:US $ 160.62M 4.87M
Surmodics SRDX:US $ 31.15M 31.02M
Tandem Diabetes Care TNDM:US $ 112.38M 13.8M
Trinity Biotech TRIB:US $ 27.48M 1.14M
Varian Medical Systems VAR:US $ 773.3M 7.2M